Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

AMRXAMRX
Showing 8 of 30 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in AMNEAL PHARMACEUTICALS INC

GEODE CAPITAL MANAGEMENT, LLC holds 4.5M shares of AMRX (AMNEAL PHARMACEUTICALS INC), worth $56.5M as of 2026-Q1. The position was increased (+14.0% shares). AMRX represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$56.5M

Current Shares

4.5M

Total Value Change

+$34.9M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
4.5M
+14.0%
$56.5M0.0%$13.31
33
2025-Q4
Decreased
4M
-1.2%
$50.2M0.0%$12.88
0
2025-Q3
Increased
4M
+7.3%
$40.4M0.0%$9.87
31
2025-Q2
Decreased
3.8M
-1.7%
$30.4M0.0%$8.13
0
2025-Q1
Increased
3.8M
+0.3%
$32.1M0.0%$8.28
29
2024-Q4
Increased
3.8M
+0.7%
$30.2M0.0%$7.83
29
2024-Q3
Increased
3.8M
+11.1%
$31.5M0.0%$8.19
32
2024-Q2
Increased
3.4M
+22.9%
$21.6M0.0%$6.35
34

Other major holders of AMRX: BlackRock, Inc., VANGUARD GROUP INC, UBS Group AG

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used